RVMD
Revolution Medicines Inc.Stock · Health CareNasdaq Composite 0.07% · US Stock Market 0.05% · Russell 1000 0.05% · Russell 3000 0.05% · MSCI World 0.03% · MSCI ACWI 0.02%$190.95-3.04%
as of market close, Sep 18, 2026
☾ AH — —
RVMD financial statements
The full income statement, balance sheet, and cash-flow statement for Revolution Medicines Inc. (RVMD), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 167.0M2024-09 168.2M2024-12 185.9M2025-03 186.3M2025-06 186.9M2025-09 193.3M2025-12 198.2M2026-03 212.6M2026-06 214.3M+28.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 0.00 | 0.00-100.0% | 11.6M-67.3% | 35.4M+20.4% | 29.4M-31.6% | |
| 1.18B+71.5% | 690M+38.2% | 499M+69.8% | 294M+35.1% | 217M+41.5% | ||
| Research & development | 987M+66.7% | 592M+40.0% | 423M+67.2% | 253M+35.4% | 187M+41.4% | |
| Selling, general & administrative | 195M+100.5% | 97.3M+28.7% | 75.6M+86.3% | 40.6M+33.3% | 30.4M+42.1% | |
| General & administrative | 195M+100.5% | 97.3M+28.7% | 75.6M+86.3% | 40.6M+33.3% | 30.4M+42.1% | |
| Amortization of intangibles | 870K-18.6% | 1.07M+0.1% | 1.07M-0.1% | 1.07M+0.0% | 1.07M+0.1% | |
| Operating income | -1.18B-71.5% | -690M-41.5% | -487M-88.6% | -258M-37.4% | -188M-69.8% | |
| Interest expense | 24.2M | 0.00 | 0.00 | 0.00-100.0% | 12.0K-83.1% | |
| Interest & investment income | 90.7M+4.4% | 86.9M+83.0% | 47.5M+418.7% | 9.15M+885.4% | 929K-58.5% | |
| Other non-operating income | 51.1M-42.4% | 88.7M+87.5% | 47.3M+416.6% | 9.15M+898.3% | 917K-57.7% | |
| Pre-tax income | -1.13B-88.3% | -601M-36.6% | -440M-76.6% | -249M-33.2% | -187M-72.4% | |
| Income tax | 0.00+100.0% | -753K+78.6% | -3.52M-739.0% | -420K | 0.00+100.0% | |
| -1.13B-88.5% | -600M-37.5% | -436M-75.5% | -249M-32.9% | -187M-73.0% | ||
| Net income to common | -1.13B-88.5% | -600M-37.5% | -436M-75.5% | -249M-32.9% | -187M-69.5% | |
| -$5.95-66.2% | -$3.58+7.3% | -$3.86-25.3% | -$3.08-19.8% | -$2.57-27.9% | ||
| EPS (basic) | -$5.95-66.2% | -$3.58+7.3% | -$3.86-25.3% | -$3.08-19.8% | -$2.57-27.9% | |
| Weighted-avg shares (basic) | 190M+13.3% | 168M+48.2% | 113M+40.3% | 80.6M+10.7% | 72.8M+32.7% | |
| Weighted-avg shares (diluted) | 190M+13.3% | 168M+48.2% | 113M+40.3% | 80.6M+10.7% | 72.8M+32.7% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 2.08B-10.9% | 2.33B+23.9% | 1.88B+184.7% | 660M+11.9% | 590M+29.9% | ||
| Cash & equivalents | 384M-29.3% | 543M-22.0% | 696M+331.3% | 161M+48.8% | 108M+4.1% | |
| Short-term investments | 1.64B-6.0% | 1.75B+51.0% | 1.16B+139.2% | 484M+3.2% | 469M+39.3% | |
| Prepaid expenses | 49.4M+28.8% | 38.3M+52.9% | 25.1M+137.2% | 10.6M+55.7% | 6.79M-2.8% | |
| 2.35B-8.0% | 2.56B+24.1% | 2.06B+153.9% | 812M+10.0% | 738M+30.1% | ||
| Property, plant & equipment | 33.2M+36.7% | 24.3M+6.2% | 22.9M+22.5% | 18.7M+61.6% | 11.5M+29.7% | |
| Operating lease right-of-use | 132M+12.4% | 118M+52.3% | 77.1M+40.1% | 55.1M-7.7% | 59.7M+117.6% | |
| Goodwill | 14.6M+0.0% | 14.6M+0.0% | 14.6M+0.0% | 14.6M+0.0% | 14.6M+0.0% | |
| Intangible assets | 55.8M-1.5% | 56.7M-1.9% | 57.7M-1.8% | 58.8M-1.8% | 59.9M-1.8% | |
| Other non-current assets | 14.8M+748.4% | 1.74M-75.2% | 7.03M+146.1% | 2.86M+276.9% | 758K+148.5% | |
| 290M+77.2% | 164M+13.9% | 144M+132.1% | 62.0M+2.7% | 60.4M+27.9% | ||
| Accounts payable | 64.6M+18.7% | 54.4M-11.9% | 61.8M+190.0% | 21.3M+51.6% | 14.1M+11.5% | |
| Accrued liabilities | 5.00M | — | — | — | — | |
| Deferred revenue | — | — | 0.00-100.0% | 4.46M-63.9% | 12.4M+2.0% | |
| Current lease liability | 16.5M+27.9% | 12.9M+74.7% | 7.37M+8.8% | 6.77M+9.0% | 6.21M+69.2% | |
| Other current liabilities | 7.86M+1247.9% | 583K-85.0% | 3.90M+671.5% | 505K+62.4% | 311K+220.6% | |
| 723M+146.7% | 293M+24.5% | 236M+85.8% | 127M-6.4% | 135M+46.0% | ||
| Deferred revenue (non-current) | — | — | — | 0.00-100.0% | 6.57M-22.5% | |
| Non-current lease liability | 142M+15.7% | 123M+52.6% | 80.6M+40.3% | 57.4M-4.9% | 60.4M+108.4% | |
| Operating lease liability (total) | 159M+16.8% | 136M+54.5% | 87.9M+37.0% | 64.2M-3.6% | 66.6M+104.0% | |
| Deferred tax liabilities | 2.35M+0.0% | 2.35M-24.5% | 3.12M-55.7% | 7.03M-5.6% | 7.44M+0.0% | |
| Other non-current liabilities | 1.21M+80.3% | 670K-54.0% | 1.46M+384.4% | 301K-52.5% | 634K+0.3% | |
| 1.63B-28.0% | 2.27B+24.0% | 1.83B+166.5% | 685M+13.7% | 603M+26.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 19.0K+5.6% | 18.0K+12.5% | 16.0K+77.8% | 9.00K+12.5% | 8.00K+14.3% | |
| Additional paid-in capital | 4.50B+12.4% | 4.00B+35.0% | 2.96B+113.5% | 1.39B+31.5% | 1.06B+42.6% | |
| Retained earnings | -2.87B-65.1% | -1.74B-52.7% | -1.14B-62.2% | -701M-54.9% | -453M-70.5% | |
| Accumulated other comprehensive income | 3.24M+145.0% | 1.32M+142.8% | 544K+130.6% | -1.78M-373.4% | -376K-424.1% | |
| Total liabilities & equity | 2.35B-8.0% | 2.56B+24.1% | 2.06B+153.9% | 812M+10.0% | 738M+30.1% | |
| Common shares issued | 197M+6.0% | 186M+9.2% | 170M+88.3% | 90.4M+21.9% | 74.1M+11.3% | |
| Common shares outstanding | 197M+6.0% | 186M+12.9% | 165M+82.1% | 90.4M+21.9% | 74.1M+11.3% | |
| Shares outstanding (cover) | 198M+6.6% | 186M+12.9% | 165M+82.0% | 90.5M+22.0% | 74.2M+1.1% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -898M-61.0% | -557M-59.0% | -351M-56.2% | -224M-52.5% | -147M-47.1% | ||
| Depreciation & amortization | 7.78M+18.6% | 6.56M+30.1% | 5.04M+26.9% | 3.97M+28.8% | 3.08M+18.1% | |
| Intangible amortization | 870K-18.6% | 1.07M+0.1% | 1.07M-0.1% | 1.07M+0.0% | 1.07M+0.1% | |
| Share-based compensation | 118M+49.5% | 79.2M+28.2% | 61.8M+98.0% | 31.2M+50.5% | 20.7M+133.2% | |
| Deferred income taxes | 0.00+100.0% | -738K+80.8% | -3.85M-816.2% | -420K | — | |
| Change in receivables | 0.00+100.0% | -1.25M+63.3% | -3.42M-172.2% | -1.26M-170.7% | -464K+80.2% | |
| Change in payables | 9.54M+247.5% | -6.46M-119.9% | 32.5M+345.5% | 7.29M+225.5% | 2.24M+634.1% | |
| 118M+121.3% | -554M-61.8% | -343M-1320.6% | -24.1M+83.0% | -142M+39.3% | ||
| Capital expenditure | 16.0M+55.1% | 10.3M+33.4% | 7.73M-28.5% | 10.8M+65.7% | 6.53M+122.6% | |
| Free cash flow | -914M-60.9% | -568M-58.5% | -358M-52.3% | -235M-53.0% | -154M-49.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 622M-35.2% | 959M-21.9% | 1.23B+307.8% | 301M+2.5% | 294M-30.4% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00-100.0% | 728M+124.8% | 324M+30.5% | 248M-11.7% | 281M-33.1% | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -158M-3.8% | -152M-128.4% | 536M+913.0% | 52.9M+983.9% | 4.88M-94.5% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 15.8B+94.1% | 8.13B+158.8% | 3.14B+48.6% | 2.11B+13.3% | 1.87B-35.7% | |
| P/S | — | — | 90.3×+25.9% | 71.7×+12.8% | 63.5×-6.0% | |
| P/B | 9.7×+169.5% | 3.6×-4.3% | 3.8×+20.9% | 3.1×+0.2% | 3.1×-49.4% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: RVMD’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RVMD filings on SEC EDGAR → Not investment advice.